Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted benzimidazoles and their use for inducing apoptosis

Substituted benzimidazoles and their use for inducing apoptosis

US Patent 7423157 · Granted Sep 9, 2008

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical combinations for use in the treatment of neoplastic diseases2022
5′S-LNA nucleotides and oligonucleotides2022
Use of phospho-Akt as a biomarker of drug response2020
Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles2020
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles2019
Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazo2018
Use of phospho-Akt as a biomarker of drug response2018
Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles2018
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles2018
Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazo2016
Use of stathmin as a biomarker of drug response to furazanobenzimidazoles2016
Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases2014